Cargando…

Prognostic factors in the non-Hodgkin's lymphomas--a time for consensus?

Detalles Bibliográficos
Autor principal:	Child, J. A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972544/ https://www.ncbi.nlm.nih.gov/pubmed/2069841

Ejemplares similares

Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.
por: Cowan, R. A., et al.
Publicado: (1989)

Prognostic Factors in Hodgkin Lymphoma
por: Cuccaro, Annarosa, et al.
Publicado: (2014)

DNA content and prognosis of non-Hodgkin's lymphoma.
por: Morgan, D. R., et al.
Publicado: (1986)

Beta-2 microglobulin: a prognostic factor in diffuse aggressive non-Hodgkin's lymphomas.
por: Johnson, P. W., et al.
Publicado: (1993)

Proliferating cell nuclear antigen (PCNA) as a prognostic factor in non-Hodgkin's lymphoma.
por: Klemi, P. J., et al.
Publicado: (1992)

Prognostic factors in HIV-positive patients with non-Hodgkin lymphoma: a Peruvian experience
por: Cuellar, Luis Ernesto, et al.
Publicado: (2018)

Primary gastric non-Hodgkin's lymphoma in Chinese patients: clinical characteristics and prognostic factors
por: Huang, JiaJia, et al.
Publicado: (2010)

Non-Hodgkin's Lymphomas
por: Proctor, S.J.
Publicado: (1994)

Prognostic factors in non-Hodgkin's lymphoma: the importance of symptomatic stage as an adjunct to the Kiel histopathological classification.
por: Leonard, R. C., et al.
Publicado: (1983)

Immunohistochemical and other prognostic factors in B cell non Hodgkin lymphoma patients, Kampala, Uganda
por: Tumwine, Lynnette K, et al.
Publicado: (2009)

Primary Non-Hodgkin Lymphoma of the Stomach: Clinicopathological Characteristics and Prognostic Factors in Iranian Patients
por: Hosseini, Sare, et al.
Publicado: (2014)

Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin's Lymphoma (High Grade)
por: Doval, Dinesh Chandra, et al.
Publicado: (2017)

Blood transfusion as a risk factor for non-Hodgkin lymphoma.
por: Brandt, L., et al.
Publicado: (1996)

Frontline Therapy for Classical Hodgkin Lymphoma by Stage and Prognostic Factors
por: Allen, Pamela B, et al.
Publicado: (2017)

Lymphocyte markers in non-Hodgkin's lymphomas.
por: Payne, S. V., et al.
Publicado: (1977)

Peripheral T Cell Non-Hodgkin's Lymphoma following Treatment of Hodgkin's Lymphoma
por: Chang, Sun Hee, et al.
Publicado: (2015)

Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma
por: Eberth, Sonja, et al.
Publicado: (2010)

Association of Human Cytomegalovirus with Hodgkin’s Disease and Non-Hodgkin’s lymphomas
por: Mehravaran, Hamide, et al.
Publicado: (2017)

Association of HHV-6 with Hodgkin and non Hodgkin lymphoma
por: Kiani, Hadis, et al.
Publicado: (2016)

Prognostic Value of miRNA-155 Expression in B-Cell Non-Hodgkin Lymphoma
por: Bedewy, Ahmed M. L., et al.
Publicado: (2017)

The classic prognostic factors in advanced Hodgkin’s lymphoma patients are losing their meaning at the time of Pet-guided treatments
por: Bari, Alessia, et al.
Publicado: (2019)

Assessing Prognostic Factors in Hodgkin's Lymphoma: Multistate Illness-Death Model
por: Javanmardi, Fatemeh, et al.
Publicado: (2018)

Evaluation of Occupational Risk Factors in Non-Hodgkin Lymphoma and Hodgkin's Disease in Iranian Men
por: Aminian, Omid, et al.
Publicado: (2012)

Diet and non-Hodgkin's lymphoma risk
por: Mozaheb, Zahra, et al.
Publicado: (2012)

Immunophenotyping of Non-Hodgkin's lymphomas in Sudan
por: Hamid, Khalid Hamad, et al.
Publicado: (2014)

Gastric non-Hodgkin’s lymphoma
por: Tzimourtos, Vassilios, et al.
Publicado: (2014)

Surgery for Non-Hodgkin’s Lymphoma
por: Weledji, Elroy Patrick, et al.
Publicado: (2015)

Epidemiology of Non-Hodgkin’s Lymphoma
por: Thandra, Krishna C., et al.
Publicado: (2021)

Immunotherapies in Non-Hodgkin’s Lymphoma
por: Bezombes, Christine, et al.
Publicado: (2021)

The real risk of secondary non-Hodgkin lymphoma following classical Hodgkin lymphoma
por: Dogan, Ahmet
Publicado: (2022)

The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
por: Gronowitz, J. S., et al.
Publicado: (1983)

The Outcome of Hodgkin Lymphoma With Reference to Prognostic Markers
por: Ahmed, Rehana, et al.
Publicado: (2022)

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma
por: Khan, Muhammad Rahil, et al.
Publicado: (2018)

Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma
por: Liang, Zheng, et al.
Publicado: (2014)

Non-Hodgkin's lymphoma: A review
por: Singh, Rohit, et al.
Publicado: (2020)

A Retrospective Analysis of Primary Gastrointestinal Non-Hodgkin Lymphomas: Clinical Features, Prognostic Factors and Treatment Outcomes
por: Tian, Chen, et al.
Publicado: (2020)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

A critical analysis of prognostic factors for survival in intermediate and high grade non-Hodgkin's lymphoma. Scotland and Newcastle Lymphoma Group Therapy Working Party.
por: Hayward, R. L., et al.
Publicado: (1991)

p53 protein expression and its prognostic importance in patients with nodal non-Hodgkin's lymphoma.
por: Ahn, M. J., et al.
Publicado: (2000)

Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma.
por: Radford, J. A., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_2bg1ibp9tvv6vo55ulkab8ajsd